|
Volumn 8, Issue 2, 2004, Pages 140-150
|
Antiretroviral therapy during pregnancy and early neonatal life: consequences for HIV-exposed, uninfected children.
a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;
LAMIVUDINE;
PROTEINASE INHIBITOR;
ZIDOVUDINE;
DISEASE TRANSMISSION;
FEMALE;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
NEWBORN;
PREGNANCY;
PREGNANCY COMPLICATION;
PREGNANCY OUTCOME;
PRENATAL EXPOSURE;
REVIEW;
ANTI-HIV AGENTS;
DISEASE TRANSMISSION, VERTICAL;
FEMALE;
HIV INFECTIONS;
HIV PROTEASE INHIBITORS;
HUMANS;
INFANT, NEWBORN;
LAMIVUDINE;
PREGNANCY;
PREGNANCY COMPLICATIONS, INFECTIOUS;
PREGNANCY OUTCOME;
PRENATAL EXPOSURE DELAYED EFFECTS;
ZIDOVUDINE;
|
EID: 15944396393
PISSN: 14138670
EISSN: None
Source Type: Journal
DOI: 10.1590/S1413-86702004000200004 Document Type: Review |
Times cited : (17)
|
References (57)
|